Evidence map›Paper›PMID 32288931›Full record

ReviewBiocatalysis and agricultural biotechnology2019

Diarylheptanoids as nutraceutical: A review.

G Ganapathy, R Preethi, J A Moses, C Anandharamakrishnan

Abstract readReview
In one paragraph

Review in Biocatalysis and agricultural biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Bioactive Metabolites ofFoods (Basel, Switzerland) · 2025
    Review
  5. Review
  6. Article
  7. Microbiology spectrum · 2023
    Article
  8. Metabolome Mining ofMetabolites · 2023
    Article
  9. Article
  10. Frontiers in pharmacology · 2023
    Article
  11. Untargeted Metabolomic Approach ofAntioxidants (Basel, Switzerland) · 2022
    Article
  12. Review
  13. Platyphylloside, a potential inhibitor from epicarp ofSaudi journal of biological sciences · 2022
    Article
  14. ASPP 092, a phenolic diarylheptanoid fromSaudi journal of biological sciences · 2021
    Article
  15. Phytochemicals with Added Value fromMolecules (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

G GanapathyComputational modeling and Nanoscale Processing Unit, Indian Institute of Food Processing Technology, Thanjavur 613005, India.
R PreethiComputational modeling and Nanoscale Processing Unit, Indian Institute of Food Processing Technology, Thanjavur 613005, India.
J A MosesComputational modeling and Nanoscale Processing Unit, Indian Institute of Food Processing Technology, Thanjavur 613005, India.
C AnandharamakrishnanComputational modeling and Nanoscale Processing Unit, Indian Institute of Food Processing Technology, Thanjavur 613005, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phenolic compounds are naturally occurring compounds present ubiquitously in plants. They have potential health benefits and substantiate evidence for their nutraceutical applications. Diarylheptanoids are part of the broad class of plant phenolics with structurally divergent compounds. They have been used in traditional medicines and homemade remedies to treat various ailments, as organoleptic additives in foods, and also for aesthetic purposes. With their potential therapeutic and organoleptic characteristics, diarylhepatanoids can be rightly termed as nutraceuticals. This review summarizes the wide range of pharmacological activities of diarylhepatanoids and nutraceutical formulations, with relevance to human health.

Indexed as

DiarylheptanoidsHuman healthNutraceuticalsPhenols

Identifiers

PMID32288931
PMCPMC7102868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.